• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks
    1. Home>
    2. Life Science Investing News>
    Loading...
    0

    How to Invest in Life Science

    Melissa Pistilli
    Sep. 07, 2022 01:15PM PST

    A breakdown of everything to know about how to invest in life science — from biotech and pharmaceuticals to medical devices and genetics.

    bonzai tree in shape of rising graph arrow

    The overarching term “life science” refers to the study of living organisms and life processes. Given the sector’s broad reach, many investors aren’t exactly sure how to invest in life science.

    To start, it’s important to understand that the industry encompasses the fields of biotechnology, pharmaceuticals, medical devices and genetics, to name just a few. Companies within each subsector research and develop innovative products, advancing technology and striving towards drug or device commercialization by way of clinical trials and patent applications, creating ample opportunities for investors to jump on board.

    Read on for an overview of these four key life science sectors and how to invest in each of them.


    1. How to invest in biotechnology?

    Biotechnology is backed by innovation, and uses cellular and biomolecular methods to improve or create products in various industries. Public biotech companies are mostly focused on the medical markets. Most biotech firms are engaged in the long-term research and development of new medicines and vaccinations.

    As it stands, there are hundreds of existing biotech products, as well as many products under development for hitherto untreatable diseases. Generally speaking, biotech products are geared towards lowering infectious disease rates, treating patients with life-threatening diseases and reducing health problems and side effects.

    2. How to invest in pharma?

    The pharmaceutical sector is perhaps the area most associated with the healthcare sector. That's because pharma companies are the backbone behind bringing new cures to the market and improving available treatments.

    However, diseases aren’t easily targeted; there’s no specific cure for all types of cancer or a direct method for stopping the various ailments that affect humanity. As such, companies in the pharmaceutical sector expand the potential of treatments and seek new ways to work with what is already in place. For example, a company might develop drugs for multiple indications or could look at addressing broader categories, such as pain.

    3. How to invest in medical devices?

    Those interested in the long-term life science investing market should look to medical technology companies that are developing devices. These entities continue to play a prominent role in every level of healthcare, and as modern medicine is rapidly advancing, medical device development must keep up.

    The medical device market covers a wide range of health and medical tools used in the treatment, mitigation, diagnosis and prevention of diseases and physical conditions.

    Some medical device examples are neurostimulation devices, surgical implants, ultrasound imaging devices, robotic medical technology and insulin pumps and pens for diabetes. Similar to how pharma companies aim to help unmet needs, medical device companies are looking to do the same through their technologies.

    4. How to invest in genetics?

    Finally, genetics is the study of genes, their variations and hereditary characteristics. As Live Science describes it, genetics involves looking at how traits are passed on through generations.

    Breaking that definition down, there are several major branches that make up the genetics tree: classical genetics, molecular genetics and evolutionary genetics. There are various other subcategories within those branches.

    When it comes to genetics investing, companies in this niche life science sector are mostly focused on four areas: DNA sequencing, genetic testing, gene therapy and genomics, which includes genome editing.

    Why invest in the life science market?

    For those interested in the life science sector, there is no shortage of investment opportunities.

    From top biotech stocks and exchange-traded funds (ETFs), to Big Pharma companies, pharma ETFs, medical device companies and genetics stocks, there are many stepping stones into life science investing.

    While the life sciences industry may seem complex, its overarching future is promising and ripe with investment opportunities now and for years to come.

    This is an updated version of an article originally published by the Investing News Network in 2013.

    Don’t forget to follow us @INN_LifeScience for real-time updates!

    Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.

    From Your Site Articles
    • Top 5 Life Science ETFs (Updated January 2022) ›
    • 5 Top Life Science Stocks on the TSX Venture 50 | INN ›
    • Plant-based Food Stocks: 10 Biggest Companies in 2022 ›
    • Top 3 Canadian Biotech Stocks of 2022 ›
    Related Articles Around the Web
    • 2022 Healthcare and Life Sciences Investment Outlook Survey ›
    https://twitter.com/INN_Resource
    https://www.linkedin.com/in/melissa-pistilli-865271a9/
    mpistilli@investingnews.com
    The Conversation (0)

    Go Deeper

    AI Powered
    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch in 2025

    Microscopic view of stem cells.

    Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

    Melissa Pistilli

    Melissa Pistilli

    Educational Content Specialist

    Melissa Pistilli has been reporting on the markets and educating investors since 2006. She has covered a wide variety of industries in the investment space including mining, cannabis, tech and pharmaceuticals. She helps to educate investors about opportunities in a variety of growth markets. Melissa holds a bachelor's degree in English education as well as a master's degree in the teaching of writing, both from Humboldt State University, California.

    Latest News

    June Quarterly Activities Report

    June Quarterly Appendix 4C

    Appendix 4C and Quarterly Activities Report - June 2025

    Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

    Quarterly Activities/Appendix 4C Cash Flow Report

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Life Science Investing News Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×
    Melissa Pistilli
    Melissa Pistilli

    Educational Content Specialist

    Melissa Pistilli has been reporting on the markets and educating investors since 2006. She has covered a wide variety of industries in the investment space including mining, cannabis, tech and pharmaceuticals. She helps to educate investors about opportunities in a variety of growth markets. Melissa holds a bachelor's degree in English education as well as a master's degree in the teaching of writing, both from Humboldt State University, California.

    Full Bio

    Follow

    Learn about our editorial policies.